1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Nagadoi, A.
Nakazawa, K.
Uda, H.
Maekawa, T.
Ishii, S.
Nishimura, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
287
593
607
10.1006/jmbi.1999.2620
10092462
Solution structure of the transactivation domain of ATF-2 comprising a zinc finger-like subdomain and a flexible subdomain.
1999
US
Genes Dev.
GEDEEP
2056
0890-9369
4
682
Erratum. Transcription Factor ATF Cdna Clones: An Extensive Family of Leucine Zipper Proteins Able to Selectively Form DNA-Binding Heterodimers
1990
US
Genes Dev.
GEDEEP
2056
0890-9369
3
2083
Transcription Factor ATF Cdna Clones: An Extensive Family of Leucine Zipper Proteins Able to Selectively Form DNA-Binding Heterodimers
1989
UK
Embo J.
EMJODG
0897
0261-4189
8
2023
Leucine Zipper Structure of the Protein Cre-BP1 Binding to the Cyclic AMP Response Element in Brain
1989
10.2210/pdb1bhi/pdb
pdb_00001bhi
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4336.971
CRE-BP1
ZINC FINGER-LIKE SUBDOMAIN OF THE TRANSACTIVATION DOMAIN
1
man
polymer
ATF-2
no
no
MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFG
MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
CDNA
9606
Homo sapiens
511693
Escherichia coli BL21
BL21
PAR2156NCO1
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1999-06-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1998-06-09
REL
REL
THE STRUCTURES OF N- AND C-TERMINI OF THE PEPTIDE FRAGMENT (MET 1 - PRO 6 AND LYS 36 - GLY 38) WERE DISORDERED AMONG THE 20 STRUCTURES.
THE 20 FINAL STRUCTURES EXHIBITED NO DISTANCE RESTRAINT VIOLATIONS GREATER THAN 0.1 ANGSTROMS AND DIHEDRAL ANGLE VIOLATIONS GREATER THAN 6.0 DEGREES.
100
20
6.3
300
K
SIMULATED ANNEALING, ENERGY MINIMIZATION
NAKAI,KIDERA,NAKAMURA
refinement
EMBOSS
structure solution
EMBOSS
600
Bruker
DMX-600
MET
1
n
1
MET
1
A
SER
2
n
2
SER
2
A
ASP
3
n
3
ASP
3
A
ASP
4
n
4
ASP
4
A
LYS
5
n
5
LYS
5
A
PRO
6
n
6
PRO
6
A
PHE
7
n
7
PHE
7
A
LEU
8
n
8
LEU
8
A
CYS
9
n
9
CYS
9
A
THR
10
n
10
THR
10
A
ALA
11
n
11
ALA
11
A
PRO
12
n
12
PRO
12
A
GLY
13
n
13
GLY
13
A
CYS
14
n
14
CYS
14
A
GLY
15
n
15
GLY
15
A
GLN
16
n
16
GLN
16
A
ARG
17
n
17
ARG
17
A
PHE
18
n
18
PHE
18
A
THR
19
n
19
THR
19
A
ASN
20
n
20
ASN
20
A
GLU
21
n
21
GLU
21
A
ASP
22
n
22
ASP
22
A
HIS
23
n
23
HIS
23
A
LEU
24
n
24
LEU
24
A
ALA
25
n
25
ALA
25
A
VAL
26
n
26
VAL
26
A
HIS
27
n
27
HIS
27
A
LYS
28
n
28
LYS
28
A
HIS
29
n
29
HIS
29
A
LYS
30
n
30
LYS
30
A
HIS
31
n
31
HIS
31
A
GLU
32
n
32
GLU
32
A
MET
33
n
33
MET
33
A
THR
34
n
34
THR
34
A
LEU
35
n
35
LEU
35
A
LYS
36
n
36
LYS
36
A
PHE
37
n
37
PHE
37
A
GLY
38
n
38
GLY
38
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
PHE
7
A
O
PHE
7
A
N
PHE
18
A
N
PHE
18
1
A
ASP
3
-118.77
78.85
1
A
LYS
5
57.45
76.02
2
A
SER
2
55.80
-127.02
2
A
ASP
4
65.51
-77.02
2
A
PRO
12
-67.13
-75.00
2
A
LEU
35
69.62
136.96
3
A
ASP
4
55.72
97.49
3
A
LYS
5
69.83
153.38
3
A
PRO
6
-65.64
-171.04
3
A
THR
34
44.59
72.04
3
A
LEU
35
66.54
64.61
3
A
LYS
36
-152.65
-51.27
3
A
PHE
37
-155.18
26.42
4
A
CYS
9
-68.64
94.29
4
A
PRO
12
-67.49
-76.79
5
A
SER
2
76.28
-53.64
5
A
THR
10
-54.12
108.32
5
A
PRO
12
-69.74
-78.80
5
A
CYS
14
-151.35
-72.91
5
A
THR
34
-134.55
-59.24
5
A
LYS
36
48.17
-162.51
5
A
PHE
37
-158.77
-48.52
6
A
MET
33
-77.00
45.49
6
A
LEU
35
-149.05
32.15
7
A
PRO
12
-66.84
-73.05
8
A
ASP
4
43.79
-109.23
8
A
CYS
14
-84.88
45.79
8
A
LEU
35
-119.83
77.23
8
A
PHE
37
-150.10
-52.46
9
A
PRO
12
-69.41
-80.65
9
A
CYS
14
-152.80
-75.15
9
A
THR
34
-168.11
-134.98
9
A
LEU
35
-142.78
48.82
10
A
CYS
14
-69.39
-70.52
10
A
LEU
35
-166.76
71.27
10
A
LYS
36
-163.27
91.70
11
A
ASP
3
65.55
166.98
11
A
LYS
36
-172.03
-105.93
11
A
PHE
37
-166.19
-149.27
12
A
PRO
12
-67.53
-70.09
12
A
CYS
14
-156.84
40.05
12
A
LEU
35
-152.53
40.33
12
A
PHE
37
-159.91
-67.22
13
A
THR
34
-151.58
68.12
13
A
LYS
36
-164.15
109.20
14
A
ASP
4
-140.28
29.81
14
A
LYS
5
48.28
71.04
14
A
PRO
12
-67.33
-73.94
14
A
THR
34
174.69
-25.85
14
A
PHE
37
75.88
-51.32
15
A
SER
2
-77.10
-79.42
15
A
ASP
3
36.24
50.87
15
A
LYS
5
70.14
116.85
15
A
PRO
6
-65.64
-175.91
15
A
PRO
12
-67.32
-76.11
16
A
SER
2
-162.57
-158.65
16
A
THR
34
75.54
-47.10
16
A
LEU
35
-156.46
-17.72
17
A
PRO
12
-69.30
-80.92
17
A
CYS
14
-151.85
-73.77
17
A
LEU
35
-157.13
-55.99
17
A
PHE
37
-101.54
46.86
18
A
PHE
37
-158.19
-53.80
19
A
ASP
3
-81.47
47.24
19
A
PRO
12
-69.24
-76.57
19
A
CYS
14
-151.22
-64.32
19
A
PHE
37
-109.73
79.74
20
A
ASP
3
65.60
-75.85
20
A
LYS
5
52.31
73.68
20
A
PHE
37
61.35
89.47
STRUCTURE OF TRANSACTIVATION DOMAIN OF CRE-BP1/ATF-2, NMR, 20 STRUCTURES
1
Y
N
A
GLU
21
A
GLU
21
HELX_P
A
GLU
32
A
GLU
32
1
H1
12
DNA-BINDING REGULATORY PROTEIN
CRE BINDING PROTEIN, ATF-2, TRANSCRIPTIONAL ACTIVATION DOMAIN, ZN FINGER, DNA-BINDING REGULATORY PROTEIN
ATF2_HUMAN
UNP
1
1
P15336
MSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARNDSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKK
ASEDDIKKMPLDLSPLATPIIRSKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTS
SDSSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPSGQTMPVAIPASITSSNVHVPAAVPLVRPVTMVPSV
PGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGSGLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQS
TSGRRRRAANEDPDEKRRKFLERNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDC
PVTAMQKKSGYHTADKDDSSEDISVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQMADQSTEPALSQIVMAPSS
QSQPSGS
1
38
1BHI
1
38
P15336
A
1
1
38
2
anti-parallel
A
PHE
7
A
PHE
7
A
CYS
9
A
CYS
9
A
GLN
16
A
GLN
16
A
PHE
18
A
PHE
18
1
P 1